Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 4, 2018
[ Thu, Oct 04th 2018
] - WOPRAI
[ Thu, Oct 04th 2018
] - WOPRAI
[ Thu, Oct 04th 2018
] - WOPRAI
[ Thu, Oct 04th 2018
] - WOPRAI
Wed, October 3, 2018
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
David Risinger Maintained (AMRX) at Buy with Decreased Target to $24 on, Oct 3rd, 2018
David Risinger of Morgan Stanley, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Buy with Decreased Target from $26 to $24 on, Oct 3rd, 2018.
David has made no other calls on AMRX in the last 4 months.
There are 4 other peers that have a rating on AMRX. Out of the 4 peers that are also analyzing AMRX, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Dewey Steadman of "Canaccord Genuity" Maintained at Hold with Increased Target to $21 on, Tuesday, August 14th, 2018
- Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $20 on, Friday, August 10th, 2018
These are the ratings of the 2 analyists that currently disagree with David
- David Buck of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $28 on, Wednesday, August 22nd, 2018
- Randall Stanicky of "RBC Capital" Upgraded from Hold to Buy on, Monday, August 13th, 2018
